Literature DB >> 25298624

Delineation of the Structural Elements of Oriental Liver Fluke PLA2 Isoforms for Potent Drug Designing.

Gururao Hariprasad1, Divya Kota1, Sundararajan Baskar Singh1, Alagiri Srinivasan1, Souparno Adhikary1.   

Abstract

Clonorchis sinensis or the Chinese liver fluke is one of the most prevalent parasites affecting a major population in the oriental countries. The parasite lacks lipid generating mechanisms but is exposed to fatty acid rich bile in the liver. A secretory phospholipase A2, an enzyme that breaks down complex lipids, is important for the growth of the parasite. The enzyme is also implicated in the pathogenesis leading up to the hepatic fibrosis and its complications including cancer. The five isoforms of this particular enzyme from the parasite therefore qualify as potential drug targets. In this study, a detailed structural and ligand binding analysis of the isoforms has been done by modeling. The overall three dimensional structures of the isoforms are well conserved with three helices and a β-wing stabilized by four disulfide bonds. There are characteristic differences at the calcium binding loop, hydrophobic channel and the C-terminal domain that can potentially be exploited for drug binding. But the most significant feature pertains to the catalytic site where the isoforms exhibit three variations of either a histidine-aspartate-tyrosine or histidine-glutamate-tyrosine or histidine-aspartate-phenylalanine. Molecular docking studies show that isoform specific residues and their conformations in the substrate binding hydrophobic channel make unique interactions with certain inhibitor molecules resulting in a perfect tight fit. The proposed ligand molecules have a predicted affinity in micro-molar to nano-molar range. Interestingly, few of the ligand binding interaction patterns is in accordance to the phylogenetic studies to thereby establish the usefulness of evolutionary mechanisms in aiding ligand design. The molecular diversity of the parasitic PLA2 described in this study provides a platform for personalized medicine in the therapeutics of clonorchiasis.

Entities:  

Keywords:  Clonorchis sinensis; Isoform specific potent drug designing; Phospholipase A2; Structural analysis

Year:  2013        PMID: 25298624      PMCID: PMC4175704          DOI: 10.1007/s12291-013-0377-1

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

1.  GEMDOCK: a generic evolutionary method for molecular docking.

Authors:  Jinn-Moon Yang; Chun-Chen Chen
Journal:  Proteins       Date:  2004-05-01

2.  The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling.

Authors:  Konstantin Arnold; Lorenza Bordoli; Jürgen Kopp; Torsten Schwede
Journal:  Bioinformatics       Date:  2005-11-13       Impact factor: 6.937

3.  Multiple sequence alignment using ClustalW and ClustalX.

Authors:  Julie D Thompson; Toby J Gibson; Des G Higgins
Journal:  Curr Protoc Bioinformatics       Date:  2002-08

4.  MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.

Authors:  Koichiro Tamura; Daniel Peterson; Nicholas Peterson; Glen Stecher; Masatoshi Nei; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2011-05-04       Impact factor: 16.240

5.  Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: Targeting and reversible inhibition by native peptides.

Authors:  Gururao Hariprasad; Manoj Kumar; Alagiri Srinivasan; Punit Kaur; Tej Pal Singh; Othayoth Jithesh
Journal:  Int J Biol Macromol       Date:  2011-01-14       Impact factor: 6.953

6.  Novel human secreted phospholipase A(2) with homology to the group III bee venom enzyme.

Authors:  E Valentin; F Ghomashchi; M H Gelb; M Lazdunski; G Lambeau
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

7.  Structure of an acidic phospholipase A2 from Indian saw-scaled viper (Echis carinatus) at 2.6 A resolution reveals a novel intermolecular interaction.

Authors:  Jayasankar Jasti; M Paramasivam; A Srinivasan; T P Singh
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-12-18

8.  Cloning, sequence analysis and homology modeling of a novel phospholipase A2 from Heterometrus fulvipes (Indian black scorpion).

Authors:  Gururao Hariprasad; Baskar Singh; Utpal Das; Abdul S Ethayathulla; Punit Kaur; Tej P Singh; Alagiri Srinivasan
Journal:  DNA Seq       Date:  2007-06

Review 9.  Integrated lipidomics in the secreted phospholipase A(2) biology.

Authors:  Makoto Murakami; Hiroyasu Sato; Yoshitaka Taketomi; Kei Yamamoto
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

10.  The draft genome of the carcinogenic human liver fluke Clonorchis sinensis.

Authors:  Xiaoyun Wang; Wenjun Chen; Yan Huang; Jiufeng Sun; Jingtao Men; Hailiang Liu; Fang Luo; Lei Guo; Xiaoli Lv; Chuanhuan Deng; Chenhui Zhou; Yongxiu Fan; Xuerong Li; Lisi Huang; Yue Hu; Chi Liang; Xuchu Hu; Jin Xu; Xinbing Yu
Journal:  Genome Biol       Date:  2011-10-24       Impact factor: 13.583

View more
  3 in total

1.  Molecular modeling of Gly80 and Ser80 variants of human group IID phospholipase A2 and their receptor complexes: potential basis for weight loss in chronic obstructive pulmonary disease.

Authors:  Mohd Imran Khan; Ashish Kumar Gupta; Domada Ratna Kumar; Manoj Kumar; Abdul Samarth Ethayathulla; Gururao Hariprasad
Journal:  J Mol Model       Date:  2016-09-01       Impact factor: 1.810

2.  Secreted phospholipase A2 of Clonorchis sinensis activates hepatic stellate cells through a pathway involving JNK signalling.

Authors:  Yinjuan Wu; Ye Li; Mei Shang; Yu Jian; Caiqin Wang; Adham Sameer A Bardeesi; Zhaolei Li; Tingjin Chen; Lu Zhao; Lina Zhou; Ai He; Yan Huang; Zhiyue Lv; Xinbing Yu; Xuerong Li
Journal:  Parasit Vectors       Date:  2017-03-16       Impact factor: 3.876

3.  Structural Modeling of Wild and Mutant Forms of Human Plasma Platelet Activating Factor-Acetyl Hydrolase Enzyme.

Authors:  Mohd Imran Khan; Gururao Hariprasad
Journal:  J Inflamm Res       Date:  2020-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.